-
Protein A/G Magnetic Co-IP/IP Kit for PINK1
2026-09-25
See how the Protein A/G Magnetic Co-IP/IP Kit can support careful investigation of PINK1 SUMOylation and mitophagy in Parkinson’s disease models. This guide connects a recent UBC9 study to practical choices in complex capture, modification analysis, and result interpretation.
-
NSC-23766 in Breast Cancer: Designing Better RAC1 Assays
2026-09-25
Explore how NSC-23766, a Rac GTPase inhibitor, can help dissect RAC1 biology in breast cancer research. This article examines what combination-treatment evidence does—and does not—show, and how to design experiments that separate pathway effects from compound-specific phenotypes.
-
E. coli Uracil-DNA Glycosylase (UDG) Guide
2026-09-24
E. coli Uracil-DNA Glycosylase (UDG), SKU K1107, excises uracil from single- and double-stranded DNA and can support PCR product contamination elimination when the contaminating DNA contains uracil. It is not active on RNA or oligonucleotides shorter than six bases, and it is intended for research use rather than diagnostic or medical applications.
-
Verapamil, TXNIP, and Osteoporosis: Study Insights
2026-09-24
A 2025 study links a TXNIP variant with femoral-neck bone mineral density and reports that verapamil reduced bone loss in ovariectomized mice. Its cell and animal findings connect TXNIP regulation to distinct osteoclast and osteoblast pathways, offering a preclinical rationale for investigating verapamil in bone remodeling.
-
LGK-974 Beyond Oncology: PORCN Inhibition in Bone
2026-09-24
LGK-974 is a potent PORCN inhibitor with applications that extend beyond Wnt-dependent cancer models. This article examines a 2025 sclerosteosis study and explains how its skeletal findings can guide pathway selection, target-engagement measurements, and interpretation of preclinical experiments.
-
Berberrubine and Selective IMPDH2 Inhibition in CRC
2026-09-23
The reference study identifies berberrubine as a selective, competitive IMPDH2 inhibitor that restricts guanine nucleotide production and suppresses colorectal cancer growth. Its combination of structure-based screening, target-engagement assays, guanosine rescue, and validation in two mouse models provides a strong framework for mechanism-led colorectal cancer research, while leaving important translational questions unresolved.
-
PNU 74654 for Wnt Signaling Pathway Studies
2026-09-22
PNU 74654 provides a soluble-in-DMSO pharmacological handle for timing-sensitive Wnt/β-catenin experiments in cancer, stem cell, and differentiation models. This guide pairs practical dosing, controls, and troubleshooting with a careful interpretation of the reference study, where GSK3 inhibition activated rather than blocked β-catenin signaling.
-
Tunable Human Intestinal Organoids for Cell-Fate Control
2026-09-22
The reference study establishes a human small intestinal organoid system that maintains strong proliferation while expanding epithelial cell diversity under a single culture condition. By combining stemness-enhancing pathway modulation with targeted control of Wnt, Notch, BMP, and BET-dependent signals, the work makes self-renewal and differentiation more reversibly tunable for organoid research.
-
YBX1–SHANK3 Methylation in Schizophrenia
2026-09-21
The reference study identifies a methylation-dependent regulatory relationship between YBX1 and SHANK3 that links peripheral blood findings with developing cortical interneurons in schizophrenia. Its combination of PBMC methylation profiling, imaging and symptom correlations, and cell-type-specific validation supports SHANK3 promoter hypermethylation as a candidate peripheral biomarker and a mechanistic clue to neurodevelopmental pathology.
-
NAD+ at the Redox–Stress Response Interface
2026-09-21
Explore how Nicotinamide Adenine Dinucleotide (NAD+) connects redox metabolism with PARP1 signaling, autophagy, and non-apoptotic caspase activity. This mechanistic guide translates recent breast cancer findings into better NAD+ assay design and interpretation.
-
Hexa His Tag Peptide: Cleaner IP Design
2026-09-20
Learn how the Hexa His tag peptide enables antibody-compatible elution of His-tagged proteins while minimizing antibody-chain carryover. This guide connects competitive elution strategy with insights from AptaBLE, a deep-learning platform for protein–aptamer interaction analysis.
-
RIPA Lysis Buffer Strong: Workflow and Troubleshooting
2026-09-19
RIPA Lysis Buffer Strong combines high detergent strength with inhibitor-free customization for protein extraction from animal cells and tissues. This guide explains how to optimize sample handling for Western blotting, immunoprecipitation, ELISA, and kinase-focused workflows while avoiding common compatibility problems.
-
6C Culture Extends Mouse Corneal Epithelial Growth
2026-09-19
An et al. developed a serum-free, feeder-free 6C culture system that combines six signaling modulators with keratinocyte-supportive calcium to preserve mouse corneal epithelial cell proliferative activity. The study links improved expansion and wound repair with reduced epithelial–mesenchymal transition, providing a practical platform for corneal epithelial biology and regenerative medicine research.
-
Indometacin, COX-2, and Pancreatic Stellate Cells
2026-09-18
The reference study identifies COX-2 as a pharmacologically relevant link between human pancreatic stellate cell activation and the desmoplastic environment of pancreatic ductal adenocarcinoma. Using viability, migration, gene-expression, protein, and immunofluorescence analyses, it shows that indometacin suppresses stellate-cell activity while reducing COX-2 and α-SMA expression.
-
Indomethacin: Practical Research Workflow
2026-09-17
Indomethacin is a nonsteroidal anti-inflammatory drug for controlled cyclooxygenase perturbation and exploratory studies of inflammation, lipid metabolism, and membrane signaling. This guide covers solvent handling, assay controls, and interpretation boundaries; it should not be used as a substitute for a pathway-specific probe or model-matched literature evidence.